BostonGene, developer of the leading AI model for tumor and immune biology, today announced that nine abstracts have been accepted at the 2026 ASCO Annual Meeting (ASCO), scheduled to take place May ...
Abstract: This paper studies signal prediction in settings where the target signal is not a continuation of an observed history but must be inferred from other simultaneously measured signals. We ...